Redmile Group LLC 13D and 13G filings for Atara Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-09-13 4:01 pm Purchase |
2024-09-03 | 13G | Atara Biotherapeutics, Inc. ATRA |
Redmile Group LLC | 579,541 9.900% |
167,485 (+40.65%) |
Filing |
| 2024-02-14 4:26 pm Purchase |
2023-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Redmile Group LLC | 412,056 9.900% |
18,557 (+4.72%) |
Filing |
| 2023-02-14 4:18 pm Purchase |
2022-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Redmile Group LLC | 393,500 9.900% |
29,551 (+8.12%) |
Filing |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Redmile Group LLC | 363,949 9.900% |
49,404 (+15.71%) |
Filing |
| 2021-02-16 4:09 pm Purchase |
2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Redmile Group LLC | 314,545 9.900% |
94,780 (+43.13%) |
Filing |